Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion VariantsHEUCKMANN, Johannes M; BALKE-WANT, Hyatt; KÜPPERS, Ralf et al.Clinical cancer research (Print). 2012, Vol 18, Num 17, pp 4682-4690, issn 1078-0432, 9 p.Article

PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFRSOS, Martin L; KOKER, Mirjam; MICHEL, Kathrin et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 8, pp 3256-3261, issn 0008-5472, 6 p.Article

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1BARBIE, David A; TAMAYO, Pablo; FRÖHLING, Stefan et al.Nature (London). 2009, Vol 462, Num 7269, pp 108-112, issn 0028-0836, 5 p.Article

ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK InhibitorsHEUCKMANN, Johannes M; HÖLZEL, Michael; RAUH, Daniel et al.Clinical cancer research (Print). 2011, Vol 17, Num 23, pp 7394-7401, issn 1078-0432, 8 p.Article

Inhibition of nuclear translocation of nuclear factor-κB despite lack of functional IκBα protein overcomes multiple defects in apoptosis signaling in human B-cell malignanciesTHOMAS, Roman K; SOS, Martin L; ZANDER, Thomas et al.Clinical cancer research. 2005, Vol 11, Num 22, pp 8186-8194, issn 1078-0432, 9 p.Article

Characteristics of Lung Cancers Harboring NRAS MutationsOHASHI, Kadoaki; SEQUIST, Lecia V; YUMEI PAN et al.Clinical cancer research (Print). 2013, Vol 19, Num 9, pp 2584-2591, issn 1078-0432, 8 p.Article

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancerPEIFER, Martin; FERNANDEZ-CUESTA, Lynnette; MENON, Roopika et al.Nature genetics. 2012, Vol 44, Num 10, pp 1104-1110, issn 1061-4036, 7 p.Article

Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance MutationSOS, Martin L; RODE, Haridas B; RUDDIGKEIT, Lars et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 3, pp 868-874, issn 0008-5472, 7 p.Article